G1 Therapeutics.

Position:RTP
 
FREE EXCERPT

G1 Therapeutics raised $47 million in a financing led by Boston-based Cormorant Asset Management that included existing investors Eshelman Ventures and Hatteras Venture Partners. The company is developing treatments for lung...

To continue reading

FREE SIGN UP